Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.

Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page
- CheckyesterdayChange DetectedA banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record itself is still replaced by a 403 error.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision: v3.7.0 is now displayed on the page. A large set of non-core metadata and term blocks were removed, simplifying the study details view.SummaryDifference19%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, representing a minor update to the ClinicalTrials.gov record.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a new version of the study record page. No changes to core study data or status are indicated.SummaryDifference0.1%

Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.